Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier

Roger Prades, Benjamí Oller-Salvia, Susanne M. Schwarzmaier, Javier Selva, María Moros, Matilde Balbi, Valeria Grazú, Jesus M. De La Fuente, Gustavo Egea, Nikolaus Plesnila, Meritxell Teixidõ, Ernest Giralt

Producción científica: Artículo en revista indizadaArtículorevisión exhaustiva

104 Citas (Scopus)

Resumen

The blood-brain barrier (BBB) is a formidable physical and enzymatic barrier that tightly controls the passage of molecules from the blood to the brain. In fact, less than 2 % of all potential neurotherapeutics are able to cross it. Here, by applying the retro-enantio approach to a peptide that targets the transferrin receptor, a full protease-resistant peptide with the capacity to act as a BBB shuttle was obtained and thus enabled the transport of a variety of cargos into the central nervous system.

Idioma originalInglés
Páginas (desde-hasta)3967-3972
Número de páginas6
PublicaciónAngewandte Chemie - International Edition
Volumen54
N.º13
DOI
EstadoPublicada - 23 mar 2015
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier'. En conjunto forman una huella única.

Citar esto